$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity. 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/50
  • A61K-009/14
  • A61K-038/00
출원번호 US-0269685 (1999-12-14)
국제출원번호 PCT/US97/18575 (1997-10-15)
§371/§102 date 19991214 (19991214)
국제공개번호 WO-9816250 (1998-04-23)
발명자 / 주소
  • Knepp Victoria Marie
  • Prestrelski Steven Joseph
  • Smith Jessica G.
  • Huang Manley T.
출원인 / 주소
  • ALZA Corporation
대리인 / 주소
    Clarke
인용정보 피인용 횟수 : 42  인용 특허 : 2

초록

This invention relates to stable non-aqueous formulations which are suspensions of proteinaceous substances or nucleic acids in non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity. More specifically, the present invention relates to stable protein or nucleic acid for

대표청구항

[ What is claimed is:] [1.]1. A stable non-aqueous composition of a biologically active agent comprising:a) a biologically active agent containing powder wherein the biologically active agent hydration in said powder is less than 10%; andb) at least one anhydrous, aprotic, hydrophobic, non-polar, lo

이 특허에 인용된 특허 (2)

  1. Meadows David L. (Mission Viejo CA), Nonaqueous fluorinated drug delivery vehicle suspensions.
  2. Meadows David L. (Mission Viejo CA), Nonaqueous thixotropic drug delivery suspensions and methods of their use.

이 특허를 인용한 특허 (42)

  1. Foldvari, Marianna; Kumar, Praveen; Docherty, John M., Biphasic lipid-vesicle compositions.
  2. Kumar, Praveen, Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery.
  3. Kumar, Praveen, Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery.
  4. Kumar, Praveen, Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery.
  5. Kumar, Praveen, Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery.
  6. Prestrelski, Steven J., Compositions for rapidly treating severe hypoglycemia.
  7. Uhland, Scott A.; Polito, Benjamin F.; Maloney, John M.; Sheppard, Jr., Norman F.; Herman, Stephen J.; Yomtov, Barry M., Containment device with multi-layer reservoir cap structure.
  8. Prescott,James H.; Kreiger,Timothy; Proos,Elizabeth R., Control of drug release by transient modification of local microenvironments.
  9. Uhland,Scott A.; Polito,Benjamin F.; Maloney,John M.; Sheppard, Jr.,Norman F.; Herman,Stephen J.; Yomtov,Barry Y., Controlled release device and method using electrothermal ablation.
  10. Prestrelski, Steven, Formulations for the treatment of diabetes.
  11. Uhland,Scott A.; Polito,Benjamin F.; Herman,Stephen J.; Santini, Jr.,John T.; Maloney,John M., Hermetically sealed microchip reservoir devices.
  12. Ausiello, Dennis; Santini, Jr., John T.; Herman, Stephen J.; Prescott, James H.; Uhland, Scott A.; Maloney, John M.; Polito, Benjamin F., Implantable device for controlled, extended delivery of parathyroid hormone.
  13. Prestrelski, Steven; Brodbeck, Kevin, Intracutaneous injection.
  14. Prestrelski, Steven; Brodbeck, Kevin, Intracutaneous paste composition.
  15. Santini, Jr., John T.; Herman, Stephen J., Medical device for sensing glucose.
  16. Ausiello,Dennis; Santini, Jr.,John T.; Herman,Stephen J.; Prescott,James H.; Uhland,Scott A.; Maloney,John M.; Polito,Benjamin F., Method and device for the controlled delivery of parathyroid hormone.
  17. Prestrelski, Steven; Sandoval, Michael; Donovan, Martin, Methods for producing stable therapeutic formulations in aprotic polar solvents.
  18. Prestrelski, Steven J., Methods for rapidly treating severe hypoglycemia.
  19. Johnson,Audrey M.; Cima,Michael J.; Langer,Robert S., Microscale lyophilization and drying methods for the stabilization of molecules.
  20. Santini, Jr., John T.; Sbiaa, Zouhair; Coppeta, Jonathan R.; Uhland, Scott A.; Sheppard, Jr., Norman F., Multi-cap reservoir devices for controlled release or exposure of reservoir contents.
  21. Santini, Jr., John T.; Sbiaa, Zouhair; Coppeta, Jonathan R.; Uhland, Scott A.; Sheppard, Jr., Norman F., Multi-opening reservoir devices for controlled release or exposure of reservoir contents.
  22. Santini, Jr., John T.; Staples, Mark A.; Herman, Stephen J., Multi-reservoir device for transdermal drug delivery and sensing.
  23. Lively, Chris Robert; DeLong, Robert, Nucleic acid coated particles suitable for temporary storage.
  24. Prestrelski, Steven; Brodbeck, Kevin, Pastes for injection of a therapeutic agent.
  25. Prestrelski, Steven; Kinzell, John, Stable formulations for parenteral injection of peptide drugs.
  26. Prestrelski, Steven; Kinzell, John, Stable formulations for parenteral injection of peptide drugs.
  27. Prestrelski, Steven; Kinzell, John, Stable formulations for parenteral injection of peptide drugs.
  28. Prestrelski, Steven; Kinzell, John, Stable formulations for parenteral injection of peptide drugs.
  29. Prestrelski, Steven J.; Scott, Nancy, Stable formulations for parenteral injection of small molecule drugs.
  30. Prestrelski, Steven; Fang, Wei-Jie; Carpenter, John F.; Kinzell, John, Stable glucagon formulations for the treatment of hypoglycemia.
  31. Maskiewicz, Victoria Knepp; Prestrelski, Steven Joseph; Smith, Jessica G.; Huang, Manley T., Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity.
  32. Liu, Kui; Desjardin, Michael A.; Hill, Beth L.; Li, Zengji, Stable suspension formulations of erythropoietin receptor agonists.
  33. Maskiewicz, Richard, Sublimable sustained release delivery system and method of making same.
  34. Maskiewicz, Richard, Sublimable sustained release delivery system and method of making same.
  35. Becker, Cyrus K.; Pfister, Jürg R.; Rescourio, Gwenaella; Venkatraman, Meenakshi S.; Zhang, Xiaoming, Treprostinil derivative compounds and methods of using same.
  36. Becker, Cyrus K.; Pfister, Jürg R.; Rescourio, Gwenaella; Venkatraman, Meenakshi S.; Zhang, Xiaoming, Treprostinil derivative compounds and methods of using same.
  37. Becker, Cyrus K.; Pfister, Jürg R.; Rescourio, Gwenaella; Venkatraman, Meenakshi S.; Zhang, Xiaoming, Treprostinil derivative compounds and methods of using same.
  38. Becker, Cyrus K.; Venkatraman, Meenakshi S.; Zhang, Xiaoming, Treprostinil derivative compounds and methods of using same.
  39. Zhang, Xiaoming; Venkatraman, Meenakshi S.; Becker, Cyrus K., Treprostinil derivatives and compositions and uses thereof.
  40. Zhang, Xiaoming; Venkatraman, Meenakshi S.; Becker, Cyrus K., Treprostinil derivatives and compositions and uses thereof.
  41. Zhang, Xiaoming; Venkatraman, Meenakshi S.; Becker, Cyrus K., Treprostinil derivatives and compositions and uses thereof.
  42. Zhang, Xiaoming; Venkatraman, Meenakshi S.; Becker, Cyrus K., Treprostinil derivatives and compositions and uses thereof.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로